Inhibition of Silencing and Accelerated Aging by Nicotinamide, a Putative Negative Regulator of Yeast Sir2 and Human SIRT1
Open accessThe DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Abstract
The Saccharomyces cerevisiae Sir2 protein is an NAD(+)-dependent histone deacetylase that plays a critical role in transcriptional silencing, genome stability, and longevity. A human homologue of Sir2, SIRT1, regulates the activity of the p53 tumor suppressor and inhibits apoptosis. The Sir2 deacetylation reaction generates two products: O-acetyl-ADP-ribose and nicotinamide, a precursor of nicotinic acid and a form of niacin/vitamin B(3). We show here that nicotinamide strongly inhibits yeast silencing, increases rDNA recombination, and shortens replicative life span to that of a sir2 mutant. Nicotinamide abolishes silencing and leads to an eventual delocalization of Sir2 even in G(1)-arrested cells, demonstrating that silent heterochromatin requires continual Sir2 activity. We show that physiological concentrations of nicotinamide noncompetitively inhibit both Sir2 and SIRT1 in vitro. The degree of inhibition by nicotinamide (IC(50) < 50 microm) is equal to or better than the most effective known synthetic inhibitors of this class of proteins. We propose a model whereby nicotinamide inhibits deacetylation by binding to a conserved pocket adjacent to NAD(+), thereby blocking NAD(+) hydrolysis. We discuss the possibility that nicotinamide is a physiologically relevant regulator of Sir2 enzymes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although NAM has been shown to be effective to increase NAD+ in tissues, it also exerts an inhibitory effect on sirtuin [88] and PARPs activity [89].”
From NAD+ Precursors Nicotinamide Mononucleotide (NMN) and Nicotinamide Riboside (NR): Potential Dietary Contribution to Health (2023) · cites this paper as [88]
In the citing paper
“Deacetylation of PGC-1α is required to sequester it in the nucleus and this cellular redistribution is prevented by nicotinamide, a potent SIRT1 inhibitor [64].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [64]
Citations
Cites
Genomic Expression Programs in the Response of Yeast Cells to Environmental Changes
Gasch, A. P., Spellman, P. T., Kao, C. M., Carmel-Harel, O., Eisen, M. B., Storz, G., Botstein, D., & Brown, P. O. (2000) · Molecular Biology of the Cell · doi:10.1091/mbc.11.12.4241 · Cited by 4,815
Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase
Imai, S.-I., Armstrong, C. M., Kaeberlein, M., & Guarente, L. (2000) · Nature · doi:10.1038/35001622 · Cited by 3,510
hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase
Vaziri, H., Dessain, S. K., Eaton, E. N., Imai, S.-I., Frye, R. A., Pandita, T. K., Guarente, L., & Weinberg, R. A. (2001) · Cell · doi:10.1016/s0092-8674(01)00527-x · Cited by 2,659
Kaeberlein, M., McVey, M., & Guarente, L. (1999) · Genes & Development · doi:10.1101/gad.13.19.2570 · Cited by 2,253
Negative Control of p53 by Sir2α Promotes Cell Survival under Stress
Luo, J., Nikolaev, A. Y., Imai, S.-I., Chen, D., Su, F., Shiloh, A., Guarente, L., & Gu, W. (2001) · Cell · doi:10.1016/s0092-8674(01)00524-4 · Cited by 2,081
Histone deacetylases and cancer: causes and therapies
Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001) · Nature reviews. Cancer · doi:10.1038/35106079 · Cited by 1,866
Lin, S.-J., Defossez, P.-A., & Guarente, L. (2000) · Science · doi:10.1126/science.289.5487.2126 · Cited by 1,775
Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans
Tissenbaum, H. A., & Guarente, L. (2001) · Nature · doi:10.1038/35065638 · Cited by 1,603
Extrachromosomal rDNA circles—a cause of aging in yeast
Sinclair, D. A., & Guarente, L. (1997) · Cell · doi:10.1016/s0092-8674(00)80493-6 · Cited by 1,500
Self-citationPosition effect at S. cerevisiae telomeres: Reversible repression of Pol II transcription
Gottschling, D. E., Aparicio, O. M., Billington, B. L., & Zakian, V. A. (1990) · Cell · doi:10.1016/0092-8674(90)90141-z · Cited by 1,345
Research works printed but not linked: 1
- Gasser, 1998, Novartis Found. Symp., 214, 114
Cited by
Items 301–400 of 1,000
Thiosuccinyl Peptides as Sirt5-Specific Inhibitors
He, B., Du, J., & Lin, H. (2012) · Journal of the American Chemical Society · doi:10.1021/ja2090417 · Cited by 85
Poljšak, B., & Milisav, I. (2016) · Rejuvenation Research · doi:10.1089/rej.2015.1767 · Cited by 91
“49 Similarly, the genetic interventions that specifically decrease NADH levels increase life span, validating the model that NADH regulates yeast longevity in response to CR. 29 On the contrary, deletion of either SIR2 or NPT1 nullified the beneficial effect of CR. 30 In addition, NAD + precursors and…”
Biological and catalytic functions of sirtuin 6 as targets for small-molecule modulators
Klein, M. A., & Denu, J. M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.011438 · Cited by 88
Guan, X., Lin, P., Knoll, E., & Chakrabarti, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107729 · Cited by 81
“Early reports on Sir2 inhibition by NAM hypothesized that the apparent noncompetitive inhibition observed in kinetic experiments might be attributable to binding of NAD in the unproductive AB mode in the presence of NAM, which binds in the C pocket, followed by a conformational rearrangement to the catalytically produ…”
BackgroundSirtuin1 and autophagy protect cells from fluoride-induced cell stress
Suzuki, M., & Bartlett, J. D. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.11.023 · Cited by 90
“Inauhzin (INZ) inhibits SIRT1 activity [75, 76].”
Emerging Roles of SIRT1 in Cancer Drug Resistance
Wang, Z., & Chen, W. (2013) · Genes & Cancer · doi:10.1177/1947601912473826 · Cited by 82
“Deleted in breast cancer 1 (DBC1) suppresses SIRT1 activity by binding to the SIRT1 catalytic core,36 in competition with the SIRT1 C-terminal intramolecular “on-switch” peptide that activates the deacetylase function.37 Active regulator of SIRT1 (AROS) positively regulates SIRT1 activity through direct interaction wi…”
BackgroundInfluentialFan, L., Cacicedo, J. M., & Ido, Y. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13303 · Cited by 86
Lang, C., Hildebrandt, A., Brand, F., Opitz, L., Dihazi, H., & Lüder, C. G. K. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002483 · Cited by 98
“(inhibits sirtuins [51]) increased H2-A/E expression of infected”
BackgroundBudding Yeast Silencing Complexes and Regulation of Sir2 Activity by Protein-Protein Interactions
Tanny, J. C., Kirkpatrick, D. S., Gerber, S. A., Gygi, S. P., & Moazed, D. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.16.6931-6946.2004 · Cited by 96
“The differences in activity between rSir2 and the native Sir2 complexes led us to test whether nicotinamide, a physiological inhibitor of Sir2 and a product of the Sir2 reaction (5), might impact the various forms of Sir2 in different ways.”
BackgroundHistone Deacetylases and Their Inhibition in Candida Species
Garnaud, C., Champleboux, M., Maubon, D., Cornet, M., & Govin, J. (2016) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.01238 · Cited by 81
“Sirtuin Inhibitors Nicotinamide is a vitamin and precursor of NAD+ and a welldescribed inhibitor of Class III HDACs, including Sir2 (Landry et al., 2000; Bitterman et al., 2002; Sanders et al., 2007).”
BackgroundStructure and chemistry of the Sir2 family of NAD+-dependent histone/protein deactylases
Marmorstein, R. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320904 · Cited by 84
SIRT6, a protein with many faces
Gertler, A. A., & Cohen, H. Y. (2013) · Biogerontology · doi:10.1007/s10522-013-9478-8 · Cited by 92
Self-citationSirtuins and the Metabolic Hurdles in Cancer
German, N. J., & Haigis, M. C. (2015) · Current Biology · doi:10.1016/j.cub.2015.05.012 · Cited by 83
“At high concentrations, nicotinamide inhibits sirtuin function [33].”
Regulation of ribosomal DNA amplification by the TOR pathway
Jack, C. V., Cruz, C., Hull, R. M., Keller, M. A., Ralser, M., & Houseley, J. M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505015112 · Cited by 89
“1B, compare lanes 2–4 and 5–7), showing that nicotinamide enhances the rDNA amplification pathway, as has previously been demonstrated for the BIR pathway (29, 30).”
BackgroundMetabolism, Compartmentation, Transport and Production of Acetate in the Cortical Brain Tissue Slice
Rae, C. D., Fekete, A. D., Kashem, M. A., Nasrallah, F. A., & Bröer, S. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0847-5 · Cited by 95
“Nicotinamide is a potent noncompetitive inhibitor of SIRT1 [63]while NAD? is a substrate although the effect of altering NAD? on SIRT activity is not well understood[64].”
InfluentialChan, P. K., Torres, R., Yandım, C., Law, P. P., Khadayate, S. P., Mauri, M., Groşan, C., Chapman‐Rothe, N., Giunti, P., Pook, M. A., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt115 · Cited by 105
“One of the possible mechanisms of action of nicotinamide is by inhibiting SIRT1 [24], which has been shown to promote heterochromatin formation by histone deacetylation, H1b recruitment and promoting the loss of transcriptionally active marks (e.”
BackgroundSpontaneous rDNA copy number variation modulates Sir2 levels and epigenetic gene silencing
Michel, A. H., Kornmann, B., Dubrana, K., & Shore, D. (2005) · Genes & Development · doi:10.1101/gad.340205 · Cited by 86
“There is now emerging evidence for complex post-translational regulation of Sir2 activity, either through PNC1 control of the inhibitor nicotinamide (Bitterman et al. 2002; Anderson et al. 2003; Gallo et al. 2004), or by modulation of NADH levels (Lin et al.”
BackgroundProtein carbonylation: Proteomics, specificity and relevance to aging
Cabiscol, E., Tamarit, J., & Ros, J. (2014) · Mass Spectrometry Reviews · doi:10.1002/mas.21375 · Cited by 81
Marcotte, P. A., Richardson, P. R., Guo, J., Barrett, L. W., Xu, N., Gunasekera, A. H., & Glaser, K. B. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2004.05.039 · Cited by 92
SIRT1 Inhibition Alleviates Gene Silencing in Fragile X Mental Retardation Syndrome
Biacsi, R. E., Kumari, D., & Usdin, K. (2008) · PLoS Genetics · doi:10.1371/journal.pgen.1000017 · Cited by 93
“Thus the available data did not rule out a role for HDACs, specifically Class III HDACs, in gene silencing in FXS.”
BackgroundInfluentialThe controversial links among calorie restriction, SIRT1, and resveratrol
Hu, Y., Liu, J., Wang, J., & Liu, Q. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.04.034 · Cited by 92
“able to inhibit the deacetylase activity of SIRT1 in in vitro fluorometric assays [56,79,92].”
Backgroundvan Leeuwen, I., & Laín, S. (2009) · Advances in cancer research · doi:10.1016/s0065-230x(09)02005-3 · Cited by 90
“Among those inhibitors that have also been tested in mammalian cells are nicotinamide (Avalos et al., 2005; Bitterman et al., 2002), that is, the natural product of the sirtuin enzymatic activity, suramin (Schuetz et al., 2007), and dihydrocoumarin (Olaharski et al., 2005).”
BackgroundZhou, X., Xu, J., Ni, Y.-H., Chen, X., Zhang, H., Zhang, X., Liu, W.-J., Luo, L., & Fu, Y. (2014) · Journal of Ovarian Research · doi:10.1186/s13048-014-0097-z · Cited by 86
“It has been clearly demonstrated that nicotinamide can inhibit Sir2 enzymes and down-regulate the expression of SIRT1 [54].”
BackgroundEvans, C., Bogan, K. L., Song, P., Burant, C. F., Kennedy, R. T., & Brenner, C. (2010) · BMC Chemical Biology · doi:10.1186/1472-6769-10-2 · Cited by 81
“Nam is a known product inhibitor of sirtuins [28] and Pnc1, encoding nicotinamidase, is induced by CR conditions and required for the longevity benefit of CR [12].”
BackgroundMultigenerational silencing dynamics control cell aging
Li, Y., Jin, M., O’Laughlin, R., Bittihn, P., Tsimring, L. S., Pillus, L., Hasty, J., & Hao, N. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1703379114 · Cited by 82
“Previous studies showed that silencing loss induced by chemical or genetic perturbations leads to increased recombination at the rDNA region and shorter life spans (22, 23).”
BackgroundTannous, C., Booz, G. W., Altara, R., Muhieddine, D. H., Mericskay, M., Refaat, M. M., & Zouein, F. A. (2020) · Acta Physiologica · doi:10.1111/apha.13551 · Cited by 84
Long‐lived yeast as a model for ageing research
Piper, P. W. (2006) · Yeast · doi:10.1002/yea.1354 · Cited by 78
“In contrast, the Sir2p upregulation with other forms of mild stress may operate mainly through a release of Sir2p from NAM inhibition, since these lifespan increases all appear to require stress induction of the nicotinamidase Pnc1p (Figure 2), an enzyme that converts NAM to nicotinic acid [2,8,20].”
BackgroundChong, Z., & Maiese, K. (2008) · Current Neurovascular Research · doi:10.2174/156720208785425666 · Cited by 78
Dou, H., Duan, Y., Zhang, X., Yu, Q., Di, Q., Song, Y., Li, P., & Gong, Y. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.009282 · Cited by 82
“J, SirT1 inhibitor NAM reduced PPAR ubiquitination level.”
BackgroundInfluentialHa, C. W., & Huh, W.-K. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkq895 · Cited by 77
“Consistent with the previous report (45,46), nicotinamide inhibited the histone deacetylase activity of Sir2 in vitro (Supplementary Figure S2A).”
BackgroundPoly(ADP-ribose) polymerase 1 at the crossroad of metabolic stress and inflammation in aging
Altmeyer, M., & Hottiger, M. O. (2009) · Aging · doi:10.18632/aging.100052 · Cited by 76
“SIRTs require NAD as substrate and are inhibited by low levels of nicotinamide [70].”
BackgroundRegulation of yeast sirtuins by NAD+ metabolism and calorie restriction
Lu, S.-P., & Lin, S.-J. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.09.030 · Cited by 76
“As mentioned above, nicotinamide (Nam) is a by-product generated during Sir2-mediated deacetylation, which is also a potent non-competitive inhibitor of Sir2 [78,80].”
BackgroundBond, D. M., Dennis, E. S., Pogson, B. J., & Finnegan, E. J. (2009) · Molecular Plant · doi:10.1093/mp/ssp021 · Cited by 82
“Nicotinamide, a derivative of vitamin B3, is a product of the SIR2 HDAC family deacetylation reaction and, when added in excess, inhibits this class of HDACs in mammals and yeast (Bitterman et al., 2002; Landry et al., 2000).”
BackgroundEffects of nutritional components on aging
Lee, D.-Y., Hwang, W., Artan, M., Jeong, D., & Lee, S. (2014) · Aging Cell · doi:10.1111/acel.12277 · Cited by 86
“Supplementation with nicotinamide, which is one form of vitamin B3, shortens the lifespan of budding yeast by decreasing the deacetylase activity of Sir2 (Bitterman et al., 2002).”
Background“SLY AS A FOXO”: New Paths with Forkhead Signaling in the Brain
Maiese, K., Chong, Z., & Shang, Y. (2007) · Current Neurovascular Research · doi:10.2174/156720207782446306 · Cited by 78
“Physiological concentrations of nicotinamide noncompetitively inhibit Sir2, suggesting that nicotinamide is a physiologically relevant regulator of Sir2 enzymes (Bitterman et al., 2002).”
BackgroundLi, M., Petteys, B. J., McClure, J. M., Valsakumar, V., Bekiranov, S., Frank, E. L., & Smith, J. S. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01590-09 · Cited by 84
“NAM is a strong sirtuin inhibitor (7, 27), and its accumulation in the absence of Pnc1 also results in silencing defects due to Sir2 inhibition (17).”
BackgroundCalorie restriction and the nutrient sensing signaling pathways
Dilova, I., Easlon, E. J., & Lin, S.-J. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6381-y · Cited by 85
NAD+ Homeostasis and NAD+-Consuming Enzymes: Implications for Vascular Health
Campagna, R., & Vignini, A. (2023) · Antioxidants · doi:10.3390/antiox12020376 · Cited by 80
“In order to boost the NAD+ synthesis, the possibility of achieve this result by administering NAM was explored, which is the precursor of NAD+, although high doses of NAM act as a SIRT1 inhibitor, dramatically reducing lifespan [44,45].”
BackgroundInhibitors to understand molecular mechanisms of NAD+-dependent deacetylases (sirtuins)
Lawson, M. K., Uciechowska, U., Schemies, J., Rumpf, T., Jung, M., & Sippl, W. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.06.003 · Cited by 84
Neuroprotection in glaucoma: recent advances and clinical translation
Guymer, C., Wood, J. P. M., Chidlow, G., & Casson, R. J. (2018) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.13336 · Cited by 80
“inhibitor of the major NAD catabolic enzymes, namely CD38, PARPs (Poly (ADP502 ribose) polymerase), and SIRTs (sirtuin)(84,86,87).”
BackgroundRegulation of autophagy and mitophagy by nutrient availability and acetylation
Webster, B. R., Scott, I., Traba, J., Han, K., & Sack, M. N. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.02.001 · Cited by 73
“In contrast, the Class III KDACs are predominantly NAD+-dependent deacetylases (Sirtuins), and as mentioned, function as sensors of the energetic status of the cell in response to the subcellular compartment levels of NAD+ and nicotinamide and/or to the ratio of NAD+:NADH [39-43].”
Park, S., Mori, R., & Shimokawa, I. (2013) · Molecules and Cells · doi:10.1007/s10059-013-0130-x · Cited by 71
“NAD+ is hydrolyzed to NAM, which inhibits SIRT1 deacetylase activities (Bitterman et al., 2002; Fulco et al., 2008; Sauve et al., 2005) and O-acetyl-ADP-ribose (Borra et al.”
BackgroundThe Effect of Resveratrol on a Cell Model of Human Aging
STEFANI, M., MARKUS, M. A., LIN, R. C. Y., PINESE, M., DAWES, I. W., & MORRIS, B. J. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1396.001 · Cited by 75
SIRT1 Modulation as a Novel Approach to the Treatment of Diseases of Aging
Blum, C. A., Ellis, J. L., Loh, C., Ng, P. Y., Perni, R. B., & Stein, R. L. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm100861p · Cited by 73
Diverse therapeutic efficacies and more diverse mechanisms of nicotinamide
Song, S. B., Park, J., Chung, G. J., Lee, I. H., & Hwang, E. S. (2019) · Metabolomics · doi:10.1007/s11306-019-1604-4 · Cited by 78
Spinal SIRT1 Activation Attenuates Neuropathic Pain in Mice
Shao, H., Xue, Q., Zhang, F., Luo, Y., Zhu, H., Zhang, X., Zhang, H., Ding, W., & Yu, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0100938 · Cited by 74
Dietary strategies with anti-aging potential: Dietary patterns and supplements
Duan, H., Pan, J., Guo, M., Li, J., Yu, L., & Fan, L. (2022) · Food Research International · doi:10.1016/j.foodres.2022.111501 · Cited by 77
Genome rearrangements caused by interstitial telomeric sequences in yeast
Aksenova, A. Y., Greenwell, P. W., Dominska, M., Shishkin, A. A., Kim, J. C., Petes, T. D., & Mirkin, S. M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1319313110 · Cited by 84
“Long yeast telomeric repeats located internally on the chromosome have been shown to repress expression of nearby genes (18, 19), and this Rap1and Sir2-dependent telomeric silencing (1) is reversed by nicotinamide (20).”
BackgroundRuggieri, S., Orsomando, G., Sorci, L., & Raffaelli, N. (2015) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2015.02.021 · Cited by 71
“Acta (2015), E D P R O O F feedback inhibition of sirtuin activity in vivo [44].”
BackgroundKato, M., & Lin, S.-J. (2014) · DNA repair · doi:10.1016/j.dnarep.2014.07.009 · Cited by 80
Sirtuins inhibitors: The approach to affinity and selectivity
Cen, Y. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.11.010 · Cited by 76
Srivastava, S., & C. Haigis, M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211798072526 · Cited by 70
“energy status of the cell [51-55].”
Protective Effects of Hydrogen Sulfide in the Ageing Kidney
Hou, C., Wang, M.-J., Sun, C., Huang, Y., Jin, S., Mu, X.-P., Chen, Y., & Zhu, Y. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/7570489 · Cited by 74
Benayoun, B. A., Batista, F., Auer, J., Dipietromaria, A., L’Hôte, D., Baere, E. B. W. D., & Veitia, R. A. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn389 · Cited by 74
Molecular Links between Caloric Restriction and Sir2/SIRT1 Activation
Wang, Y. (2014) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2014.38.5.321 · Cited by 66
Structural Basis for Nicotinamide Inhibition and Base Exchange in Sir2 Enzymes
Sanders, B. D., Zhao, K., Slama, J. T., & Marmorstein, R. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.12.022 · Cited by 77
“…glycosidic bond between nicotinamide and ADP-ribose in b-NAD+. Nicotinamide, a reaction product and noncompetitive inhibitor of Sir2 proteins (Bitterman et al., 2002; Landry et al., 2000), has also been shown to be a physiological regulator of this family of proteins (Schmidt et al., 2004).”
BackgroundPost-treatment with a novel PARG inhibitor reduces infarct in cerebral ischemia in the rat
Lu, X. M., Massuda, E., Lin, Q., Li, W., Li, J., & Zhang, J. (2003) · Brain Research · doi:10.1016/s0006-8993(03)02774-4 · Cited by 68
The circulating PBEF/NAMPT/visfatin level is associated with a beneficial blood lipid profile
Wang, P., van Greevenbroek, M. M. J., Bouwman, F. G., Brouwers, M. C. G. J., Kallen, C., Smit, E., Keijer, J., & Mariman, E. C. M. (2007) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-007-0262-y · Cited by 68
“level. This pathway may have beneficial impact on aging and longevity [9, 18 ].”
BackgroundBao, J., & Sack, M. N. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0402-y · Cited by 67
“Interestingly, nicotinamide itself inhibits sirtuin activity and nicotinamide-depletion during NAD biosynthesis inversely activates sirtuins [12].”
Audrito, V., Managò, A., Gaudino, F., Sorci, L., Messana, V. G., Raffaelli, N., & Deaglio, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01720 · Cited by 64
Role of SIRT1 in autoimmune demyelination and neurodegeneration
Martin, A., Tegla, C., Cudrici, C. D., Kruszewski, A. M., Azimzadeh, P. N., Boodhoo, D., Mekala, A. P., Rus, V., & Rus, H. (2014) · Immunologic Research · doi:10.1007/s12026-014-8557-5 · Cited by 72
“At normal concentrations, nicotinamide binds to the sirtuins, causing their inhibition [52].”
BackgroundGiammona, L. M., Fuhrken, P. G., Papoutsakis, E. T., & Miller, W. M. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06341.x · Cited by 74
“…et al, 1990; Evans et al, 2002; McLure et al, 2004), activating the phosphoinositide-3 kinase /Akt signaling pathway (Chong et al, 2004, 2005) and inhibiting the activity of both PARP (Jagtap & Szabo, 2005) and the Sir2 family of histone/protein deacetylases (sirtuins) (Bitterman et al, 2002).”
BackgroundPeng, L., Qian, M., Liu, Z., Tang, X., Sun, J. L., Jiang, Y., Sun, S., Cao, X., Pang, Q., & Liu, B. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa214 · Cited by 68
“NAM binds to a conserved pocket adjacent to that of NAD+ to inhibit SIRT6 deacetylase (43).”
BackgroundThe role of SIRT3 in mitochondrial homeostasis and cardiac adaptation to hypertrophy and aging
Sack, M. N. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.11.004 · Cited by 71
“Interestingly, nicotinamide itself inhibits sirtuin activity and nicotinamide-depletion during NAD biosynthesis inversely activates sirtuins [29].”
BackgroundThe Role of SIRT3 in the Brain Under Physiological and Pathological Conditions
Sidorova-Darmos, E., Sommer, R., & Eubanks, J. H. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00196 · Cited by 67
“Aside from the global sirtuin inhibitor nicotamide (Bitterman et al., 2002), which as discussed above inhibits SIRT3 by competing with NAD at the SIRT3 cofactor binding site (Guan et al.”
BackgroundZhang, Q., Zhou, A., Li, S., Ni, J., Tao, J., Lu, J. L., Wan, B., Li, S., Zhang, J., Zhao, S., et al. (2016) · Scientific Reports · doi:10.1038/srep30837 · Cited by 66
“Consistent with the aforesaid observations, treatment of wild-type cells with NAM (nicotinamide) 35 , an inhibitor for CobB, caused the increase of acetylation of natively expressed DnaA (Fig.”
Enzymatic transfer of acetate on histones from lysine reservoir sites to lysine activating sites
Mendoza, M. R., Egervári, G., Sidoli, S., Donahue, G., Alexander, D. C., Sen, P., Garcia, B. A., & Berger, S. L. (2022) · Science Advances · doi:10.1126/sciadv.abj5688 · Cited by 67
“For preparing yeast cultures for d3-acetate analysis, TSA and nicotinamide (dissolved in dimethyl sulfoxide) were added to liquid medium during proliferation for final concentrations of 25 M and 5 mM, respectively, as has been used in the literature (42, 43).”
MethodXu, J., Capezzone, M., Xu, X. L., & Hershman, J. M. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0215 · Cited by 67
“Depletion of nicotinamide by increased expression of nicotinate phosphoribosyltransferase gene or nicotinamidase gene increased the Sir2-dependent silencing (12–14), whereas exogenous nicotinamide decreased Sir2-dependent gene silencing (6).”
Sirtuins (histone deacetylases III) in the cellular response to DNA damage—Facts and hypotheses
Kruszewski, M. K., & Szumiel, I. (2005) · DNA repair · doi:10.1016/j.dnarep.2005.06.013 · Cited by 75
“The deacetylating activity of sirtuins depends on NAD+ and is inhibited by the reaction product, nicotinamide (IC50 23 ].”
BackgroundAmengual, J. E., Clark-Garvey, S., Kalac, M., Scotto, L., Marchi, E., Neylon, E., Johannet, P. M., Wei, Y., Zain, J. M., & O’Connor, O. A. (2013) · Blood · doi:10.1182/blood-2013-02-485441 · Cited by 65
NAD: A master regulator of transcription
Ghosh, S., George, S., Roy, U., Ramachandran, D., & Kolthur‐Seetharam, U. (2010) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2010.08.002 · Cited by 73
Armour, S. M., Bennett, E. J., Braun, C. R., Zhang, X.-Y., McMahon, S. B., Gygi, S. P., Harper, J. W., & Sinclair, D. A. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00971-12 · Cited by 62
“Using several pan-acetyl-specific antibodies, we assessed the global acetylation of USP22 in the absence or presence of TSA and NAM, broad-spectrum histone deacetylase (HDAC) and sirtuin inhibitors, respectively (77, 78).”
Self-citationSack, M. N. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00199.2011 · Cited by 70
“Interestingly, nicotinamide generated in the deacetylation reaction itself inhibits sirtuin activity, and nicotinamide depletion during NAD biosynthesis inversely activates sirtuins (9).”
BackgroundSir2 is required for Clr4 to initiate centromeric heterochromatin assembly in fission yeast
Alper, B. J., Job, G., Yadav, R. K., Shanker, S., Lowe, B. R., & Partridge, J. F. (2013) · The EMBO Journal · doi:10.1038/emboj.2013.143 · Cited by 62
“Consistent with prior studies (Bitterman et al , 2002; Avalos Figure 2 Sir2 functions redundantly with Clr3 for centromeric heterochromatin maintenance.”
Nicotinamide inhibits Plasmodium falciparum Sir2 activity in vitro and parasite growth
Prusty, D., Mehra, P., Srivastava, S., Shivange, A. V., Gupta, A. K., Roy, N., & Dhar, S. K. (2008) · FEMS Microbiology Letters · doi:10.1111/j.1574-6968.2008.01135.x · Cited by 63
“What is the cellular target of nicotinamide? It has been proposed earlier that nicotinamide is a noncompetitive inhibitor of Sir2-like enzymes (Bitterman et al., 2002).”
BackgroundInfluentialEndothelium-dependent hyperpolarization: age, gender and blood pressure, do they matter?
Leung, S. W. S., & Vanhoutte, P. M. (2015) · Acta Physiologica · doi:10.1111/apha.12628 · Cited by 65
“…cellular senescence is silent information regulator T1 (SIRT1), a nicotinamide adenine dinucleotide-dependent deacetylase that hydrolyses lysine residues in various proteins, including histones (Bitterman et al. 2002, North & Verdin 2004, Ota et al. 2007, Donmez & Guarente, 2010, Wang et al. 2011).”
BackgroundIn Vitro Antileishmanial Activity of Nicotinamide
Séréno, D., Alegre, A. M., Silvestre, R., Vergnes, B., & Ouaissi, A. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.808-812.2005 · Cited by 63
“2A, the deacetylase activity of SIRT1 is strictly dependent on the presence of 200 M NAD.”
BackgroundResultInfluentialMarcu, R., Wiczer, B. M., Neeley, C. K., & Hawkins, B. J. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.00068-14 · Cited by 62
“To mechanistically link SIRT1 to macrophage adherence, HPAECs were pretreated with the SIRT1 enzymatic inhibitors nicotinamide and suramin (51, 52) and then incubated SIR T1 SIR T2 SIR T3 SIR T4 SIR T5 SIR T6 0.”
MethodSIRT1 prevents atherosclerosis via liver-X-receptor and NF-κB signaling in a U937 cell model
ZENG, H.-T., Fu, Y., Yu, W., LIN, J.-M., Liang‐Zhou, Liu, L., & Wang, W. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1460 · Cited by 63
Aman, Y., Frank, J., Lautrup, S., Matysek, A., Niu, Z., Yang, G., Shi, L., Bergersen, L. H., Storm‐Mathisen, J., Rasmussen, L. J., et al. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.111194 · Cited by 67
“Higher doses of NAM have, however, been associated with reduced lifespan via inhibition of Sir2 activity (Bitterman et al., 2002; Gallo et al., 2004; Mitchell et al., 2018; Mouchiroud et al., 2013; Schmeisser et al., 2013; van der Horst et al., 2007).”
BackgroundNAD+ Metabolism and Regulation: Lessons From Yeast
Croft, T., Venkatakrishnan, P., & Lin, S.-J. (2020) · Biomolecules · doi:10.3390/biom10020330 · Cited by 64
“For example, NAM is both an NAD+ precursor and an inhibitor of NAD+-dependent enzymes such as sirtuins [27,28].”
BackgroundOrta‐Zavalza, E., Guerrero‐Serrano, G., Gutiérrez‐Escobedo, G., Cañas‐Villamar, I., Juárez‐Cepeda, J., Castaño, I., & De Las Peñas, A. (2013) · Molecular Microbiology · doi:10.1111/mmi.12247 · Cited by 61
“…phase cells of the parental strain (BG14) on YPD plates in the absence or presence of 10 mM nicotinamide [NAM, a physiological non-competitive inhibitor of the NAD+-dependent histone deacetylases (Bitterman et al., 2002)] and different concentrations of fluconazole (see Experimental procedures).”
MethodWang, W., Yan, C., Zhang, J., Lin, R., Lin, Q., Yang, L., Ren, F., Zhang, J., Ji, M., & Li, Y. (2013) · APOPTOSIS · doi:10.1007/s10495-013-0833-7 · Cited by 61
“Inhibitors of SIRT1 such as sirtinol and NAM have been previously reported [24, 25].”
Biswas, A., Pasquel, D., Tyagi, R. K., & Mani, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.02.048 · Cited by 61
“To analyze the specificity of SIRT1 on deacetylation of PXR, we decided to treat HepG2 cells with the SIRT1 inhibitor nicotinamide (NAM), [15], or SIRT1 activator resveratrol (res), [16], and look at the acetylation status of endogenous PXR.”
MethodInhibition of Human Sirtuins by in Situ Generation of an Acetylated Lysine−ADP−Ribose Conjugate
Asaba, T., Suzuki, T., Ueda, R., Tsumoto, H., Nakagawa, H., & Miyata, N. (2009) · Journal of the American Chemical Society · doi:10.1021/ja807083y · Cited by 66
How much successful are the medicinal chemists in modulation of SIRT1: A critical review
Kumar, A., & Chauhan, S. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.04.063 · Cited by 67
Epigenetic gene silencing alters the mechanisms and rate of evolutionary adaptation
Stajic, D., Perfeito, L., & Jansen, L. E. T. (2019) · Nature Ecology & Evolution · doi:10.1038/s41559-018-0781-2 · Cited by 63
Nicotinamide Augments the Anti-Inflammatory Properties of Resveratrol through PARP1 Activation
Yanez, M., Jhanji, M., Murphy, K. P., Gower, R. M., Sajish, M., & Jabbarzadeh, E. (2019) · Scientific Reports · doi:10.1038/s41598-019-46678-8 · Cited by 59
Liu, C., Ma, X., Zhuang, J., Liu, L., & Sun, C. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105062 · Cited by 66
Resveratrol inhibits proliferation and promotes apoptosis of osteosarcoma cells
Li, Y., Bäckesjö, C., Haldosén, L.-A., & Lindgren, U. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.03.004 · Cited by 68
“It is supposed that over 95% of Sirt1 activity is inhibited in mammalian cells due to a high nuclear concentration of nicotinamide (Bitterman et al., 2002; Sauve et al., 2005; Sauve and Schramm, 2003).”
BackgroundLu, Z., Scott, I., Webster, B. R., & Sack, M. N. (2009) · Circulation Research · doi:10.1161/circresaha.109.204974 · Cited by 61
Navigating novel mechanisms of cellular plasticity with the NAD+ precursor and nutrient nicotinamide
Li, F. (2004) · Frontiers in Bioscience · doi:10.2741/1412 · Cited by 61
“In contrast to the early externalization of membrane PS residues, the cleavage of genomic DNA into fragments is a delayed event that occurs late during PCD (65, 126-129).”
BackgroundInfluentialAfter the grape rush: Sirtuins as epigenetic drug targets in neurodegenerative disorders
Huber, K., & Superti‐Furga, G. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.01.018 · Cited by 66
Freddolino, L., Yang, J., Momen-Roknabadi, A., & Tavazoie, S. (2018) · eLife · doi:10.7554/elife.31867 · Cited by 63
“Given the apparent importance of chromatin modifications in fitness-directed tuning, we also tested the effects of nicotinamide treatment (which inhibits the sirtuin class of histone deacetylases, or HDACs ( Bitterman et al., 2002 )) on reversion of the tuned cells back to a naı¨ve state.”
Current Trends in Sirtuin Activator and Inhibitor Development
Bursch, K. L., Goetz, C. J., & Smith, B. C. (2024) · Molecules · doi:10.3390/molecules29051185 · Cited by 63
“Consistent with ~two-fold higher aqueous solubility relative to the original TM inhibitor, MDA-MB-231 breast cancer cells treated with 100 µ M of TM analog NH4-6 (Table 3) demonstrated a ~two-fold greater decrease in viability than cells treated with the original TM pseu-dopeptide inhibitor at the…”
BackgroundYoon, Y. K., Ali, M. A., Wei, A. C., Choon, T. S., Osman, H., Parang, K., & Shirazi, A. N. (2013) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2013.12.029 · Cited by 64
2‐Anilinobenzamides as SIRT Inhibitors
Suzuki, T., Imai, K., Nakagawa, H., & Miyata, N. (2006) · ChemMedChem · doi:10.1002/cmdc.200600162 · Cited by 68
The Multifaceted Role of Endothelial Sirt1 in Vascular Aging: An Update
Campagna, R., Mazzanti, L., Pompei, V., Alia, S., Vignini, A., & Emanuelli, M. (2024) · Cells · doi:10.3390/cells13171469 · Cited by 62
Shen, C., Dou, X., Ma, Y., Ma, W., Li, S., & Song, Z. (2017) · Nutrition Research · doi:10.1016/j.nutres.2017.03.005 · Cited by 63
“As nicotinamide is also the general product of SIRT1-catalyzed deacetylation reactions, high concentrations of nicotinamide has been generally used as a SIRT1 inhibitor [26-28].”
BackgroundTrichostatin A inhibits deacetylation of histone H3 and p53 by SIRT6
Wood, M., Rymarchyk, S., Zheng, S. G., & Cen, Y. (2017) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2017.12.009 · Cited by 65
Metadata
- Authors
- Bitterman, K. J., Anderson, R. M., Cohen, H. Y., Latorre-Esteves, M., & Sinclair, D. A.
- Affiliations
- Harvard University (US)
- Corresponding author
- Sinclair, David A.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-11
- Volume
- 277
- Issue
- 47
- Pages
- 45099-45107
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2167990179
- Cited by
- 1,002
- References
- 66
- Citations by year
- 2026: 16 · 2025: 24 · 2024: 32 · 2023: 33 · 2022: 36 · 2021: 41 · 2020: 38 · 2019: 39 · 2018: 47 · 2017: 43 · 2016: 43 · 2015: 58 · 2014: 40 · 2013: 58 · 2012: 56
- FWCI
- 21.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6554 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG11972-01)
- Topics
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Structure and Function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
- Keywords
- nicotinamide, Sir2, SIRT1, transcriptional silencing, heterochromatin, replicative lifespan, aging, NAD+ hydrolysis, enzyme inhibition, p53, apoptosis, histone deacetylation
- MeSH terms
- Aging, DNA, Ribosomal, Genes, Fungal, Histone Deacetylases, Humans, Life Expectancy, Luminescent Proteins, Models, Biological, Niacinamide, Recombinant Fusion Proteins, Recombination, Genetic, Saccharomyces cerevisiae, Molecular Structure, Telomere, Gene Silencing, Sirtuins, Silent Information Regulator Proteins, Saccharomyces cerevisiae, Green Fluorescent Proteins, Sirtuin 1, Sirtuin 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.